New peer-reviewed, scientific study shows Vyleesi enhances sexual brain processing in premenopausal women with HSDD. Click here to learn more ›

Palatin Technologies, Inc. to Report Fiscal Year 2011 Fourth Quarter Results; Teleconference and Webcast to be held on September 22, 2011

CRANBURY, N.J., Sept. 19, 2011 /PRNewswire/ — Palatin Technologies, Inc. (NYSE Amex: PTN) will announce its fourth quarter, fiscal year 2011 financial results on Thursday, September 22, 2011 before the open of the U.S. financial markets.

Palatin will also conduct a conference call and live audio webcast hosted by its executive management team on September 22, 2011, which will include discussion of the results of operations in greater detail and an update on corporate developments.

Schedule for the Financial Results Press Release, Conference Call / Webcast



Q4 & Fiscal Year 2011 Financial Results Press Release

9/22/2011 at 7:30 a.m. ET



Q4 & Fiscal Year 2011 Conference Call-Live

9/22/2011 at 11:00 a.m. ET

Domestic Dial-In Number

1-800-281-7970

International Dial-In Number

1-913-312-0671

Pass code

9488233



Q4 & Fiscal Year 2011 Conference Call-Replay

9/22-9/29/2011

Domestic Dial-In Number

1-888-203-1112

International Dial-In Number

1-719-457-0820

Pass code

9488233



Webcast Live and Replay Access

http://www.palatin.com

The webcast and replay can be accessed by logging on to the “Investor/Media Center-Webcasts”
section of Palatin’s website at http://www.palatin.com

About Palatin Technologies, Inc.

Palatin Technologies, Inc. is a biopharmaceutical company developing targeted, receptor- specific peptide therapeutics for the treatment of diseases with significant unmet medical need and commercial potential. Palatin’s strategy is to develop products and then form marketing collaborations with industry leaders in order to maximize their commercial potential.  For additional information regarding Palatin, please visit Palatin Technologies’ website at www.palatin.com.

SOURCE Palatin Technologies, Inc.

Scroll to Top